| Literature DB >> 27638438 |
Samia Esmat1, Wedad Mostafa2, Rehab A Hegazy2, Suzan Shalaby2, Vaneeta Sheth3, Randa Youssef2, Medhat El-Mofty2.
Abstract
Phototherapy has been the mainstay of vitiligo therapy for several decades. A variety of wavelengths and modalities are available, but narrowband ultraviolet B remains the safest and most commonly used treatment. Acting on multiple steps in vitiligo pathogenesis, narrowband ultraviolet B is one of the few therapies that can effectively induce stabilization and stimulate repigmentation. Achievement of optimal results involves using a combination of appropriate treatment protocols, careful patient selection, and patient education to set expectations. Individual patient characteristics, including disease activity, vitiligo phenotype, lesion location, and skin phototype, should all be considered, along with combination therapies.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27638438 DOI: 10.1016/j.clindermatol.2016.05.009
Source DB: PubMed Journal: Clin Dermatol ISSN: 0738-081X Impact factor: 3.541